Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA
对 PATRICIA 随机试验进行事后分析,评估人乳头瘤病毒 16 型 (HPV-16)/HPV-18 AS04 佐剂疫苗预防非疫苗致癌性 HPV 类型新发感染和持续感染的有效性,采用一种替代的多重类型特异性 PCR 检测方法检测 HPV DNA
期刊:Clinical and Vaccine Immunology
影响因子:
doi:10.1128/CVI.00457-14
Struyf, Frank; Colau, Brigitte; Wheeler, Cosette M; Naud, Paulo; Garland, Suzanne; Quint, Wim; Chow, Song-Nan; Salmerón, Jorge; Lehtinen, Matti; Del Rosario-Raymundo, M Rowena; Paavonen, Jorma; Teixeira, Júlio C; Germar, Maria Julieta; Peters, Klaus; Skinner, S Rachel; Limson, Genara; Castellsagué, Xavier; Poppe, Willy A J; Ramjattan, Brian; Klein, Terry D; Schwarz, Tino F; Chatterjee, Archana; Tjalma, Wiebren A A; Diaz-Mitoma, Francisco; Lewis, David J M; Harper, Diane M; Molijn, Anco; van Doorn, Leen-Jan; David, Marie-Pierre; Dubin, Gary